2018

• Besneux, M.et al. 2018. The nature of the human T cell response to the cancer antigen 5T4 is determined by the balance of regulatory and inflammatory T cells of the same antigen-specificity: implications for vaccine design. Cancer Immunology, Immunotherapy (10.1007/s00262-018-2266-1)
• Soliman, F. and Hargest, R. 2018. Intestinal failure in gastrointestinal fistula patients. Surgery (Oxford) 36(5), pp. 245-251. (10.1016/j.mpsur.2018.03.001)
• Sahnan, K.et al. 2018. Developing a core outcome set for fistulising perianal Crohn's disease. Gut (10.1136/gutjnl-2017-315503)
• Hargest, R. 2018. Randomized controlled trial of standard closure of a stoma site vs biological mesh reinforcement: study protocol of the ROCSS trial. Colorectal Disease 20(2), pp. O46-O54. (10.1111/codi.13997)

2017

• Osman, B.et al. 2017. Migration of ventriculoperitoneal shunt to urethral and rectal orifices. BMJ Case Reports 2017, article number: 220187. (10.1136/bcr-2017-220187)
• Zabkiewicz, C.et al. 2017. Bone morphogenetic proteins, breast cancer, and bone metastases: striking the right balance. Endocrine-Related Cancer 24(10), pp. R349-R66. (10.1530/ERC-17-0139)
• Zabkiewicz, C.et al. 2017. Increased expression of follistatin in breast cancer reduces invasiveness and clinically correlates with better survival. Cancer Genomics Proteomics 14(4), pp. 241-251. (10.21873/cgp.20035)
• Lee, M.et al. 2017. Association of Coloproctology of Great Britain and Ireland consensus exercise on surgical management of fistulating perianal Crohn's disease. Colorectal Disease 19(5), pp. 418-429. (10.1111/codi.13672)
• Gu, Y.et al. 2017. NHERF1 regulates the progression of colorectal cancer through the interplay with VEGFR2 pathway. Oncotarget 8(5), pp. 7753-7765. (10.18632/oncotarget.13949)

2016

• Hargest, R. 2016. Feasibility study from a randomized controlled trial of standard closure of a stoma sitevsbiological mesh reinforcement. Colorectal Disease 18(9), pp. 889-896. (10.1111/codi.13310)
• Cornish, J.et al. 2016. Hughes Abdominal Repair Trial (HART) - Abdominal wall closure techniques to reduce the incidence of incisional hernias: study protocol for a randomised controlled trial. Trials 17(1), pp. 454. (10.1186/s13063-016-1573-0)
• Teagle, A. R., Birchall, J. C. and Hargest, R. 2016. Gene therapy for pyoderma gangrenosum: optimal transfection conditions and effect of drugs on gene delivery in the HaCaT cell line using cationic liposomes. Skin Pharmacology and Physiology 29, pp. 119-129. (10.1159/000444859)
• Satherley, L.et al. 2016. Prostate Apoptosis Response-4 (PAR4) suppresses growth and invasion of breast cancer cells and is positively associated with patient survival. Anticancer Research 36(3), pp. 1227-1236.
• Greensmith, M., Cho, J. and Hargest, R. 2016. Changes in surgical training opportunities in Britain and South Africa. International Journal of Surgery 25, pp. 76-81. (10.1016/j.ijsu.2015.11.052)

2015

• Soliman, F., Sturgeon, G. and Hargest, R. 2015. Revisiting an ancient treatment for transphincteric fistula-in-ano 'There is nothing new under the sun' Ecclesiastes 1v9. Journal of the Royal Society of Medicine 108(12), pp. 482-489. (10.1177/0141076815588322)
• Collins, R. J.et al. 2015. EPLIN: a fundamental actin regulator in cancer metastasis?. Cancer and Metastasis Reviews 34(4), pp. 753-764. (10.1007/s10555-015-9595-8)
• Li, J.et al. 2015. MTA1 is up-regulated in colorectal cancer and is inversely correlated with lymphatic metastasis. Cancer Genomics and Proteomics 12(6), pp. 339-346.
• Satherley, L.et al. 2015. Downstream of tyrosine kinase 7 (DOK7) variant expression and function in human colorectal cancer [Abstract]. European Journal of Cancer 51(S3), pp. S27. (10.1016/S0959-8049(15)30004-6)
• Ji, J.et al. 2015. WISP-2 in human gastric cancer and its potential metastatic suppressor role in gastric cancer cells mediated by JNK and PLC-γ pathways. British Journal of Cancer 113(6), pp. 921-933. (10.1038/bjc.2015.285)
• Ji, K.et al. 2015. VILIP-1 plays a suppressive role in the motility of colorectal cancer cells and the inhibition involves the regulation of mmps via jnk signalling pathway. Anticancer Research 35(7), pp. 4332-4333.
• Satherley, L.et al. 2015. Expression of lymphangiogenic factors Vegf-C and Vegf-D and impact of Vegf-D knockout on tubule formation in human colorectal cancer [Abstract]. British Journal of Surgery 102(s1), pp. 8-8., article number: 700. (10.1002/bjs.9735)

2014

• Teagle, A. and Hargest, R. 2014. Management of pyoderma gangrenosum. Journal of the Royal Society of Medicine 107(6), pp. 228-236. (10.1177/0141076814534407)
• Satherley, L.et al. 2014. DOK7 expression in colorectal cancer cells and association with clinical and prognostic outcome [Abstract]. British Journal of Surgery 101(S4), pp. 12., article number: O34. (10.1002/bjs.9508)
• Jia, Y.et al. 2014. Death-associated protein-3, DAP-3, correlates with preoperative chemotherapy effectiveness and prognosis of gastric cancer patients following perioperative chemotherapy and radical gastrectomy. British Journal of Cancer 110(2), pp. 421-429. (10.1038/bjc.2013.712)
• Power, K.et al. 2014. A case-control study of risk factors for wound infection in a colorectal unit. Annals of the Royal College of Surgeons of England 96(1), pp. 37-40. (10.1308/003588414X13824511650137)
• Jia, Y.et al. 2014. Death associated protein 1 is correlated with the clinical outcome of patients with colorectal cancer and has a role in the regulation of cell death. Oncology Reports 31(1), pp. 175-182. (10.3892/or.2013.2866)
• Ji, K.et al. 2014. Implication of metastasis suppressor gene, Kiss-1 and its receptor Kiss-1R in colorectal cancer. BMC Cancer 14, article number: 723. (10.1186/1471-2407-14-723)

2013

• Scurr, M.et al. 2013. Escalating regulation of 5T4-specific IFN- + CD4+ T cells distinguishes colorectal cancer patients from healthy controls and provides a target for in vivo therapy. Cancer Immunology Research 1(6), article number: 416. (10.1158/2326-6066.CIR-13-0035)
• Scurr, M. J.et al. 2013. Highly prevalent colorectal cancer-infiltrating LAP+ Foxp3- T cells exhibit more potent immunosuppressive activity than Foxp3+ regulatory T cells. Mucosal Immunology n/a (10.1038/mi.2013.62)
• Frewer, N.et al. 2013. Potential implication of IL-24 in lymphangiogenesis of human breast cancer. International Journal of Molecular Medicine 31(5), pp. 1097-1104. (10.3892/ijmm.2013.1319)
• Chong, R.et al. 2013. Gene silencing following siRNA delivery to skin via coated steel microneedles: In vitro and in vivo proof-of-concept. Journal of Controlled Release 166(3), pp. 211-219. (10.1016/j.jconrel.2012.12.030)
• Frewer, K.et al. 2013. A role for WISP2 in colorectal cancer cell invasion and motility. Cancer Genomics and Proteomics 10(4), pp. 187-196.
• Chong, R. H.et al. 2013. Gene silencing following siRNA delivery to skin via coated steel microneedles: In vitro and in vivo proof-of-concept. Journal of Controlled Release 166(3), pp. 211. (10.1016/j.jconrel.2012.12.030)

2012

• Blake, P.et al. 2012. Large bowel obstruction due to colorectal carcinoma can be safely treated by colonic stent insertion - case series from a UK district general hospital. Colorectal Disease 14(12), pp. 1489-1492. (10.1111/j.1463-1318.2012.03035.x)
• Ji, K.et al. 2012. Expression of signal-induced proliferation-associated gene 1 (SIPA1), a rapGTPase-activating protein, is increased in colorectal cancer and has diverse effects on functions of colorectal cancer cells. Cancer Genomics and Proteomics 9(5), pp. 321-327.

2011

• Chong, R.et al. 2011. Nucleic acid delivery to skin for the potential treatment of dermatopathogenic conditions [Abstract]. Human Gene Therapy 22(10), pp. A82-A82.
• Teagle, A., Birchall, J. C. and Hargest, R. 2011. The effect of drugs commonly used for pyoderma gangrenosum on the efficiency of gene transfer to human keratinocytes. Human Gene Therapy 22(10), pp. A94-A94.
• Teagle, A., Birchall, J. C. and Hargest, R. 2011. The effect of drugs commonly used for pyoderma gangrenosum on the efficiency of gene transfer to human keratinocytes [Abstract]. British Journal of Surgery 98, pp. 40-40. (10.1002/bjs.7577/abstract)

2010

• Hardwicke, J.et al. 2010. The use of the Flexi-Seal®Faecal Management System in laparostomy wounds involving enterocutaneous fistula. Annals of the Royal College of Surgeons of England 92(4), pp. e12-e14. (10.1308/147870810X12659688851834)
• Zimbwa, T. A.et al. 2010. An unusual complication of colitis. Gut 59(3), pp. 364-364. (10.1136/gut.2009.179689)

2009

• Stephens, M. and Hargest, R. 2009. The post-CCT subconsultant grade: the case against / the case for. Bulletin of The Royal College of Surgeons of England 91(4), pp. 124-126. (10.1308/147363509X423788)

2008

• Ganapathi, S., Evans, G. and Hargest, R. 2008. Bilateral breast metastases of a renal carcinoma: a case report and review of the literature. BMJ Case Reports 2008(Nov 12), article number: bcr0620080239. (10.1136/bcr.06.2008.0239)